Chemotherapy pharmacodynamics and neuroimaging and neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 34, Issue 22, 2016, Pages 2644-2653

  Krull, Kevin R ^a   Cheung, Yin Ting ^a   Liu, Wei ^a   Fellah, Slim ^a   Reddick, Wilburn E ^a   Brinkman, Tara M ^a   Kimberg, Cara ^a   Ogg, Robert ^a   Srivastava, Deokumar ^a   Pui, Ching Hon ^a   Robison, Leslie L ^a   Hudson, Melissa M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; ASPARAGINASE MACROGOL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; FOLINIC ACID; HOMOCYSTEINE; HYDROCORTISONE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BRAIN CORTEX; BRAIN REGION; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CHILDHOOD LEUKEMIA; DIFFUSION TENSOR IMAGING; DORSOLATERAL PREFRONTAL CORTEX; DRUG BLOOD LEVEL; DRUG MEGADOSE; EXECUTIVE FUNCTION TEST; FEMALE; FOLLOW UP; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INTELLIGENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PHARMACOKINETIC ASSAY; PRIORITY JOURNAL; TREATMENT OUTCOME; WHITE MATTER; WORKING MEMORY; BLOOD; CHILD; DIAGNOSTIC IMAGING; DRUG EFFECTS; EXECUTIVE FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREFRONTAL CORTEX; STATISTICAL MODEL;

ADOLESCENT; CHILD; EXECUTIVE FUNCTION; FEMALE; FRONTAL LOBE; HUMANS; INTELLIGENCE; LINEAR MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; NEUROIMAGING; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREFRONTAL CORTEX; TREATMENT OUTCOME;

EID: 85002590585     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.65.4574     Document Type: Article

References (32)

1. Pui CH, Campana D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730-2741, 2009
2. Bhojwani D, Sabin ND, Pei D, et al: Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 32:949-959, 2014
3. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group long-term follow-up guidelines from the Children's Oncology Group late effects committee and nursing discipline. J Clin Oncol 22:4979-4990, 2004
4. Krull KR, Brinkman TM, Li C, et al: Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: A report from the St Jude lifetime cohort study. J Clin Oncol 31:4407-4415, 2013
5. Conklin HM, Krull KR, Reddick WE, et al: Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst 104:1386-1395, 2012
6. Spiegler BJ, Kennedy K, Maze R, et al: Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 24:3858-3864, 2006
7. Kadan-Lottick NS, Brouwers P, Breiger D, et al: Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 27:5986-5992, 2009
8. Rühs H, Becker A, Drescher A, et al: Population PK/PD model of homocysteine concentrations after high-dose methotrexate treatment in patients with acute lymphoblastic leukemia. PLoS One 7:e46015, 2012
9. Kishi S, Griener J, Cheng C, et al: Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 21:3084-3091, 2003
10. Yang L, Panetta JC, Cai X, et al: Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol 26:1932-1939, 2008
11. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System. Psychological Cortp, San Antonio, TX, 2001
12. Wechsler D. Wechsler Abbreviated Scale of Intelligence. Psychological Corp, San Antonio, TX, 1999
13. Wechsler D. Wechsler Intelligence Scale for Children (ed 4). Harcourt Assessment, San Antonio, TX, 2003
14. Wechsler D. Wechsler Adult Intelligence Scale (ed 4). Pearson, San Antonio, TX, 2008
15. Conners CK. Conners' Continuous Performance Performance Test II. Multi-Health Systems, North Tonawanda, NY, 2001
16. Strauss E, Sherman EM, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (ed 3). New York, NY, Oxford University Press, 2006
17. Fan J, McCandliss BD, Fossella J, et al: The activation of attentional networks. Neuroimage 26:471-479, 2005
18. Reuter M, Schmansky NJ, Rosas HD, et al: Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 61:1402-1418, 2012
19. Zeller B, Tamnes CK, Kanellopoulos A, et al: Reduced neuroanatomic volumes in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 31:2078-2085, 2013
20. Schuitema I, de Sonneville L, Kaspers G, et al: Executive dysfunction 25 years after treatment with cranial radiotherapy for pediatric lymphoid malignancies. J Int Neuropsychol Soc 21:657-669, 2015
21. Schuitema I, Deprez S, Van Hecke W, et al: Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. J Clin Oncol 31:3378-3388, 2013
22. Yang L, Hu X, Xu L: Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: A meta-analysis. Tumour Biol 33:1445-1454, 2012
23. Dulucq S, Laverdière C, Sinnett D, et al: Pharmacogenetic considerations for acute lymphoblastic leukemia therapies. Expert Opin Drug Metab Toxicol 10:699-719, 2014
24. Chechik G, Meilijson I, Ruppin E: Neuronal regulation: A mechanism for synaptic pruning during brain maturation. Neural Comput 11:2061-2080, 1999
25. Gogtay N, Giedd JN, Lusk L, et al: Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 101:8174-8179, 2004
26. Carey ME, Haut MW, Reminger SL, et al: Reduced frontal white matter volume in long-term childhood leukemia survivors: A voxel-based morphometry study. AJNR Am J Neuroradiol 29:792-797, 2008
27. Reddick WE, Glass JO, Johnson DP, et al: Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia. AJNR Am J Neuroradiol 30:1947-1954, 2009
28. Krull KR, Bhojwani D, Conklin HM, et al: Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 31:2182-2188, 2013
29. Drozdowicz LB, Bostwick JM: Psychiatric adverse effects of pediatric corticosteroid use. Mayo Clin Proc 89:817-834, 2014
30. Edelmann MN, Ogg RJ, Scoggins MA, et al: Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort. Pediatr Blood Cancer 60:1778-1784, 2013
31. DreslerM,GenzelL,KlugeM,etal:Off-line memory consolidation impairments in multiple sclerosis patients receiving high-dose corticosteroid treatment mirror consolidation impairments in depression. Psychoneuroendocrinology 35:1194-1202, 2010
32. Andreotti C, Root JC, Ahles TA, et al: Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline. Psychooncology, 24:617-623, 2014